BidaskClub Lowers Mesoblast Limited (MESO) to Strong Sell
BidaskClub downgraded shares of Mesoblast Limited (NASDAQ:MESO) from a sell rating to a strong sell rating in a report published on Friday morning.
Several other research firms also recently weighed in on MESO. Zacks Investment Research raised Mesoblast Limited from a hold rating to a buy rating and set a $13.00 price objective for the company in a research note on Monday, April 24th. Maxim Group reaffirmed a buy rating and issued a $14.00 price objective on shares of Mesoblast Limited in a research note on Tuesday, April 11th. Scotiabank reaffirmed a hold rating and issued a $8.50 price objective on shares of Mesoblast Limited in a research note on Monday, April 3rd. Cantor Fitzgerald reaffirmed an overweight rating on shares of Mesoblast Limited in a research note on Thursday, June 8th. Finally, Credit Suisse Group set a $11.00 price objective on Mesoblast Limited and gave the company a hold rating in a research note on Tuesday, July 18th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. Mesoblast Limited presently has a consensus rating of Hold and an average price target of $12.70.
Mesoblast Limited (MESO) traded down 0.14% during trading on Friday, reaching $6.95. The company’s stock had a trading volume of 450 shares. Mesoblast Limited has a 52 week low of $4.01 and a 52 week high of $12.50. The company’s market capitalization is $552.83 million. The company has a 50 day moving average price of $7.72 and a 200-day moving average price of $8.16.
A hedge fund recently raised its stake in Mesoblast Limited stock. Princeton Capital Management Inc. increased its stake in Mesoblast Limited (NASDAQ:MESO) by 15.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 155,700 shares of the company’s stock after buying an additional 20,945 shares during the period. Princeton Capital Management Inc. owned 0.20% of Mesoblast Limited worth $1,398,000 at the end of the most recent reporting period. 2.91% of the stock is owned by hedge funds and other institutional investors.
About Mesoblast Limited
Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.